Bioinformatics‐based discovery of the involvement of PSAT1 in mediating the anti‐lung adenocarcinoma activity of triptolide
Animal Models and Experimental Medicine · 2026
DOI: 10.1002/ame2.70120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2026. Verfasst von Zhiwen Cao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Provincial Key Laboratory of Molecular Medicine, The Second Affiliated Hospital of Nanchang University, Jiangxi Medical College, Nanchang Uni…. Hauptthemen laut MEDLINE: Phenanthrenes, Diterpenes, Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Science and Technology New Star Program Cross-cooperation Project, Jiangxi Provincial Natural Science Foundation.
Abstract (Originalsprache)
Background
Triptolide (TP) exhibits various pharmacological activities. Our previous studies have confirmed the efficacy of TP against lung adenocarcinoma (LUAD). However, the potent pharmacological activity of TP is underpinned by its complex mechanisms. Exploring its potential mechanisms is of great value for promoting the clinical application of TP and extending its clinical use.
Methods
Differentially expressed genes (DEGs) associated with LUAD were analyzed and acquired from the TCGA database, while DEGs related to TP were obtained through RNA sequencing. Hub genes were identified through LASSO and random forest models. The efficacy of TP against LUAD was validated using tumor‐bearing mouse models and A549 cells. The validation of hub genes was conducted using RT‐qPCR. The regulatory effect of hub genes on TP efficacy was validated through overexpression cell models. Furthermore, the potential mechanisms by which TP improves gemcitabine (GEM) resistance were explored using a GEM‐resistant cell line in combination with the overexpression model.
Results
This study validated the therapeutic effect of TP against LUAD in vivo and in vitro. Bioinformatics revealed that the mechanism of TP's effect against LUAD might be associated with amino acid‐related biological processes. Five hub genes were screened and identified by combining bioinformatics methods and experiments. The overexpression model validated that PSAT1 plays an effective role in the efficacy of TP and in alleviating GEM resistance.
Conclusion
This study preliminarily demonstrated that the anti‐LUAD effect of TP was associated with the PSAT1‐regulated serine biosynthesis pathway, and that TP effectively improves GEM resistance by inhibiting PSAT1 expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangxi Provincial Key Laboratory of Molecular Medicine, The Second Affiliated Hospital of Nanchang University, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Department of Genetic Medicine, The Second Affiliated Hospital of Nanchang University, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
- Department of Endocrinology, Dongfang Hospital of Beijing University of Chinese Medicine, Beijing, China.
ORCID-Profile: Cheng Lu
Förderung
- National Natural Science Foundation of China
- Beijing Science and Technology New Star Program Cross-cooperation Project
- Jiangxi Provincial Natural Science Foundation
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Cao, Z., Zhang, L., Zhang, W., Wan, R., Peng, X., Xie, J., Bai, R., Jin, J., Shi, C., Yan, L., Guo, X., Shen, Y., & Lu, C. (2026). Bioinformatics‐based discovery of the involvement of PSAT1 in mediating the anti‐lung adenocarcinoma activity of triptolide. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.70120
Vancouver
Cao Z, Zhang L, Zhang W, Wan R, Peng X, Xie J, et al. Bioinformatics‐based discovery of the involvement of PSAT1 in mediating the anti‐lung adenocarcinoma activity of triptolide. Animal Models and Experimental Medicine. 2026. doi:10.1002/ame2.70120
BibTeX
@article{Cao2026,
author = {Cao, Zhiwen and Zhang, Lulu and Zhang, Wenqiang and Wan, Rong and Peng, Xiaogang and Xie, Jinyan and Bai, Ruru and Jin, Jiejing and Shi, Changqi and Yan, Lan and Guo, Xiangyu and Shen, Yang and Lu, Cheng},
title = {Bioinformatics‐based discovery of the involvement of PSAT1 in mediating the anti‐lung adenocarcinoma activity of triptolide},
journal = {Animal Models and Experimental Medicine},
year = {2026},
doi = {10.1002/ame2.70120}
}
EUVIMED